Methods This retrospective cohort study utilized data from the Global Collaborative Network in TriNetX, spanning January 1, 2006, to June 1, 2023
Liraglutide Liraglutide is a glucagon-like peptide-1 (GLP-1) agonist, originally marketed for the treatment of type 2 diabetes (T2D)
Carnitine may also support healthy glucose metabolism, contributing to overall metabolic health.* Applications Athletes and active individuals seeking to optimize fatty acid metabolism for energy production* Those looking to support mitochondrial function and cellular energy* Individuals seeking brain health support alongside cardiovascular benefits* Those whose carnitine levels may be impacted by aging, medications, or metabolic factors* Individuals seeking a synergistic dual-form carnitine supplement in an optimized ratio* Key Ingredients / Formula Highlights L-Carnitine (400 mg per serving) Provided as L-carnitine tartrate to promote normal cellular energy production through fatty acid transport into the mitochondria for beta-oxidation.* Acetyl-L-Carnitine (100 mg per serving) The acetylated form of carnitine that crosses into the mitochondrial membrane to support energy production, with specific additional support for brain health.* Optimized 4:1 Ratio The 4:1 ratio of L-carnitine to acetyl-L-carnitine provides synergistic support for both systemic energy metabolism and targeted neurological benefits
Several drugs have been developed to treat T2DM such as glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase 4 inhibitors, and sodium-glucose co-transporter 2 inhibitors
Your provider will recommend a schedule that fits your goals and response to treatment
